Healthcare -
Biotechnology - NASDAQ - US
$ 1.595
2.61 %
$ 452 M
Market Cap
-2.75
P/E
ERAS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ERAS - Erasca, Inc.
-157 M
LAST VALUE
-48.44%
2 YEAR CAGR
-49.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR